graph pad instat software-1.13 version (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
graph pad instat software-1.13 version
Graph Pad Instat Software 1.13 Version, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graph+pad+instat+software-1%2E13+version/instat+1+14+software/pm21110773-101-15-20
Average 90 stars, based on 1 article reviews
Graph Pad Instat Software 1.13 Version, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/graph+pad+instat+software-1%2E13+version/instat+1+14+software/pm21110773-101-15-20
Average 90 stars, based on 1 article reviews
graph pad instat software-1.13 version - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Design and development of gliclazide-loaded chitosan for oral sustained drug delivery: in vitro/in vivo evaluation. Article Snippet: Gliclazide (GLZ)/Chitosan microparticles were prepared with tripolyphosphate (TPP) by ionic cross-linking.. The particle sizes of TPP–chitosan microparticles were in the range 675–887 mm and the loading efficiencies of drug was more than 94.0%.. Chitosan concentration, TPP solution pH and glutaraldehyde volume added to the TPP cross-linking solution had an effect on the drug release characteristics. Article Title: Glipizide matrix transdermal systems for diabetes mellitus: preparation, in vitro and preclinical studies. Article Snippet: The aim of the present investigation was to prepare glipizide matrix transdermal systems using the combinations of ethyl cellulose/ polyvinylpyrrolidone and Eudragit RL-100/Eudragit RS-100.. The systems were evaluated for various in vitro (drug content, drug permeation, scanning electron microscopy and drug–polymer interactions) and in vivo (acute and long-term hypoglycemic activity, biochemical and histopathological studies, skin irritation and pharmacokinetic studies in mice) parameters.. Drug content of the patches was found to be more than 98%. Article Title: Preparation and characterization of chitosan microparticles for oral sustained delivery of gliclazide: in vitro/in vivo evaluation Article Snippet: Chitosan microparticles were prepared with tripolyphosphate (TPP) by ionic cross-linking with gliclazide (GLZ) as a model drug.. The particle sizes of TPP-chitosan microparticles ranged from 675–887 mm with loading efficiencies of greater than 94%.. Chitosan concentration, TPP solution pH, and glutaraldehyde volume solution added to the TPP cross-linking solution affected drug release characteristics. |